Hyperliquid Strategies Completes $2.5 Billion Facility Expansion
On September 1, Hyperliquid Strategies increased its equity financing facility with Chardan Capital Markets from $1 billion to $2.5 billion, as revealed in a recent filing with the U.S. Securities and Exchange Commission.
Summary
- Hyperliquid Strategies has elevated the cap of its equity facility with Chardan from $1 billion to $2.5 billion.
- This facility allows for periodic share sales without assuring that the company will acquire the complete $2.5 billion.
- Funds raised may be directed toward various corporate goals, including the prospective acquisition of HYPE, contingent upon specific conditions.
- An exchange limit of 42,641,847 shares will apply for particular sales priced below $12.02 after the initial $1 billion is raised.
- PURR closed at $11.36 on September 1, showing a drop of roughly 7.3% during the regular trading session.
The Nasdaq-traded company has the ability to incrementally generate funds by selling newly issued PURR shares to Chardan. Hyperliquid Strategies has indicated that the proceeds from this facility might be allocated for various corporate needs, including possible acquisitions of HYPE, the native asset of the Hyperliquid ecosystem.
The $2.5 billion figure represents the maximum limit of the facility. It does not imply that the company has raised this full amount, completed a corresponding offering, or earmarked the funds for purchasing HYPE.
The actual funds raised will be contingent upon the number of shares sold and the sell price. Each issuance will also increase the total share count of PURR, potentially diluting existing shareholders.
Hyperliquid Strategies expands capacity by $1.5 billion
The updated ChEF purchase agreement between Hyperliquid Strategies and Chardan was signed on September 1, with the original pact dating back to October 22, 2025.
This amendment raises the total commitment by $1.5 billion. Chardan has the right to acquire newly issued common shares from Hyperliquid Strategies after the company files qualifying purchase notices under the agreement.
Hyperliquid Strategies retains control over the timing and volume of individual sales. Its SEC filings indicate that financing choices will be influenced by market conditions, the trading price of PURR, and management’s evaluation of the optimal use of proceeds.
This setup differs from a traditional loan. Selling shares does not involve principal repayments or interest obligations. However, the company exchanges equity for cash, which may reduce the ownership percentage represented by each existing share.
The facility does not guarantee that Chardan will purchase $2.5 billion worth of shares. Transactions must still comply with the terms, conditions, and restrictions set forth in the agreement, meaning the total amount raised could be less than the maximum commitment.
HYPE acquisitions remain discretionary
Hyperliquid Strategies mentioned in its prospectus that proceeds from equity facility sales are allocated for general corporate purposes, including the possibility of HYPE purchases.
This language grants management considerable flexibility. There is no minimum allocation mandated for HYPE, no deadline for acquisitions, nor specified token targets. The company might use the funds for operational expenses, transaction fees, or other corporate necessities.
The Form 8-K filed on September 1 does not disclose any new HYPE acquisitions and does not clarify whether Hyperliquid Strategies has executed share sales using the increased $1.5 billion capacity.
As of August 19, Hyperliquid Strategies reported owning 29.3 million HYPE tokens. Since completing its business combination in December 2025, the company invested $773.4 million to acquire approximately 16.5 million tokens at an average price of $46.77, according to crypto.news.
Additionally, the company reported holding $149.9 million in cash at the end of June and claimed to carry no debt. Its HYPE inventory has grown significantly from around 12.6 million tokens at the company’s inception.
Related reports suggested that the transaction establishing Hyperliquid Strategies included $305 million in cash along with the initial HYPE allocation. Since then, the company has generated equity financing as a central element of its token acquisition strategy.
Nasdaq rules impose restrictions on lower-priced offerings
The amendment enforces an exchange cap that will come into play once cumulative share sales through the facility hit $1 billion.
After reaching this threshold, Hyperliquid Strategies generally cannot sell more than 42,641,847 shares at prices under $12.02. This limit represents 19.99% of common shares outstanding before the amendment took effect.
The company may exceed this cap if shareholders grant approval for additional issuances in accordance with Nasdaq regulations. The restriction could also be lifted if shareholder consent is not required per relevant Nasdaq provisions.
At a price of $12.02 per share, 42,641,847 shares would yield approximately $512.5 million in gross proceeds. This estimate excludes fees and assumes all shares are sold at the stated price.
The relationship between the share cap and the expanded commitment could limit access to the full facility when PURR trades below $12.02. Raising the full $2.5 billion might necessitate higher selling prices, shareholder approval, or a pertinent Nasdaq exemption.
The impacts on current investors will vary based on the timing and volume sold during each issuance. Selling shares at lower prices requires issuing more stock to attain the same cash amount, leading to greater dilution.
PURR closes under the amendment’s threshold
PURR concluded at $11.36 on September 1, down about 7.3% during the regular trading session. The stock opened at $11.76 and fluctuated between $11.03 and $12.31, with trading volume nearing 24.3 million shares.
The closing price placed PURR below the amendment’s $12.02 benchmark. However, the market price alone does not activate the exchange cap. The restriction applies only to completed sales beneath the threshold following cumulative transactions through the facility exceeding $1 billion.
